EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical …
Objective: To develop evidence based recommendations for the management of hip
osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised …
osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised …
Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients
A Rostom, L Goldkind, L Laine - Clinical Gastroenterology and Hepatology, 2005 - Elsevier
Background & Aims: Nonsteroidal anti-inflammatory drugs (NSAIDs) might cause hepatic
side effects, but the frequency of these laboratory and clinical side effects is uncertain …
side effects, but the frequency of these laboratory and clinical side effects is uncertain …
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty
Objective The impact of increasing utilization of total knee arthroplasty (TKA) on lifetime
costs in persons with knee osteoarthritis (OA) is understudied. Methods We used the …
costs in persons with knee osteoarthritis (OA) is understudied. Methods We used the …
[HTML][HTML] Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and …
Objectives There is an important need to evaluate therapeutic approaches for osteoarthritis
(OA) in terms of cost-effectiveness as well as efficacy. Methods The ESCEO expert working …
(OA) in terms of cost-effectiveness as well as efficacy. Methods The ESCEO expert working …
Cost‐effectiveness acceptability curves–facts, fallacies and frequently asked questions
Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to
quantify and graphically represent uncertainty in economic evaluation studies of health‐care …
quantify and graphically represent uncertainty in economic evaluation studies of health‐care …
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from …
AD Sawitzke, H Shi, MF Finco, DD Dunlop… - Annals of the …, 2010 - ard.bmj.com
Background Knee osteoarthritis (OA) is a major cause of pain and functional limitation in
older adults, yet longer-term studies of medical treatment of OA are limited. Objective To …
older adults, yet longer-term studies of medical treatment of OA are limited. Objective To …
Optimal cost‐effectiveness decisions: the role of the cost‐effectiveness acceptability curve (CEAC), the cost‐effectiveness acceptability frontier (CEAF), and the …
GR Barton, AH Briggs, EAL Fenwick - Value in health, 2008 - Wiley Online Library
Objective: To demonstrate how the optimal decision and level of uncertainty associated with
that decision, can be presented when assessing the cost‐effectiveness of multiple options …
that decision, can be presented when assessing the cost‐effectiveness of multiple options …
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
JA Singh, R Ramachandaran, S Yu… - BMC cardiovascular …, 2017 - Springer
Background Few studies, if any, have examined cardiovascular outcomes in patients with
diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The …
diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The …
Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump …
S Jarupongprapa, P Ussavasodhi… - Journal of …, 2013 - Springer
Background There are conflicting and inconsistent data regarding the gastrointestinal (GI)
protective effect of cyclooxygenase-2 (COX-2) inhibitors and of non-steroidal anti …
protective effect of cyclooxygenase-2 (COX-2) inhibitors and of non-steroidal anti …
[HTML][HTML] Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
OBJECTIVE: Disease-modifying osteoarthritis drugs (DMOADs) are under development. Our
goal was to determine efficacy, toxicity, and cost thresholds under which DMOADs would be …
goal was to determine efficacy, toxicity, and cost thresholds under which DMOADs would be …